Stock Market Reaction – Talk Bio

Actionable Insights Powered by AI

GlycoMimetics’ Uproleselan Fails to Meet Primary Endpoint in Leukemia Clinical Trial

12 months ago talkbio0Tagged Clinical Trials, GlycoMimetics, leukemia, Primary Endpoint, Stock Market Reaction, Uproleselan

GlycoMimetics, Uproleselan, Leukemia, Clinical Trial, Primary Endpoint, Stock Market Reaction

Gritstone Cancer Vaccine Trial Misses Primary Endpoint, Stock Plummets

1 year ago talkbio0Tagged Circulating, Circulating Tumor DNA, Colorectal Carcinoma, Gritstone, Personalized Neoantigen Cancer Vaccine, Phase 2 Clinical Trials, Progression-Free Survival, Stock Market Reaction

Gritstone, Personalized Neoantigen Cancer Vaccine, Colorectal Cancer, Phase 2 Study Failure, Circulating Tumor DNA (ctDNA), Progression-Free Survival (PFS), Stock Market Reaction